ArticleTrials2026

Bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir plus lamivudine plus tenofovir disoproxil fumarate in people living with HIV experiencing virologic failure in China: a study protocol for a multicenter, open-label, randomized controlled non-inferiority trial.

Ran Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.